Searched for
BIOCON CANCER DRUG LAUNCH
Biocon clears path for cancer drug launchBiocon has finalized a global settlement and license agreement with Genentech for its drug Pebrilzo. This agreement addresses all ongoing l...- Protect patients and patents smartlyThe Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...
- Pope Leo cancer diagnosis: What is lung adenocarcinoma, symptoms, treatments & who are at riskPope Leo has been found to have lung adenocarcinoma, which is among the most common types of lung cancer. He recently had surgery to excise...
- Punjab anti-drug activist murder: Main accused nabbed from RajasthanAshwani Kumar, the medical store owner, was arrested in Rajasthan after allegedly killing anti-drug activist Parvinder Singh Jhota. Jhota w...
- Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
- Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growthKiran Mazumdar-Shaw emphasized the importance of building an innovation-driven pharmaceutical industry in India. She highlighted the need f...
- LIC to launch three new insurance plans on October 19, 2026: Annuity, health insurance and cancer cover to go on offerLife Insurance Corporation of India is set to introduce three new insurance products on October 19, 2026. The offerings include LIC’s New J...
- Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...
- SC asks govt to broaden inflated pricing review beyond oncologyThe Supreme Court has asked the government to address high markups on medicines and medical devices. The court questioned the decision to l...
- Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and developmentThe Ministry of Science has entered into a partnership with Peptris Technologies to bolster drug development under the initiative called VI...
- Supreme Court questions govt over drug pricing, asks why cap limited to anti-cancer medicinesThe Supreme Court expressed its worry over the government's restriction of price control measures to only anti-cancer drugs, questioning wh...
- Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-ShawBiocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push f...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Form panel to curb pharma freebies: SCThe Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is t...
- Govt set to cap trade margins on more cancer drugs before SC hearingThe Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda w...
- Hospital pricing part of wider value chain: Max MDAbhay Soi, chairman of Max Healthcare, commented on scrutiny regarding hospital pricing in India. He stated that hospitals should be evalua...
- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
- British Indian pair, accused of cancer drug fraud, fight extradition to USA British Indian businessman and his ex-wife are fighting extradition to the US over allegations that they defrauded Medicare and other hea...
- Cancer drug costs Rs 2,700, sells for Rs 27,000: SC questions 10x markup at hospitalsThe Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The c...
Load More
